APA (7th ed.) Citation

Serreze, D. V., Chapman, H. D., Niens, M., Dunn, R., Kehry, M. R., Driver, J. P., . . . Atkinson, M. A. (2011). Loss of Intra-Islet CD20 Expression May Complicate Efficacy of B-Cell–Directed Type 1 Diabetes Therapies. Diabetes (New York, N.Y.), 60(11), 2914-2921. https://doi.org/10.2337/db11-0705

Chicago Style (17th ed.) Citation

Serreze, David V., Harold D. Chapman, Marijke Niens, Robert Dunn, Marilyn R. Kehry, John P. Driver, Michael Haller, Clive Wasserfall, and Mark A. Atkinson. "Loss of Intra-Islet CD20 Expression May Complicate Efficacy of B-Cell–Directed Type 1 Diabetes Therapies." Diabetes (New York, N.Y.) 60, no. 11 (2011): 2914-2921. https://doi.org/10.2337/db11-0705.

MLA (9th ed.) Citation

Serreze, David V., et al. "Loss of Intra-Islet CD20 Expression May Complicate Efficacy of B-Cell–Directed Type 1 Diabetes Therapies." Diabetes (New York, N.Y.), vol. 60, no. 11, 2011, pp. 2914-2921, https://doi.org/10.2337/db11-0705.